Financials
Financial year 2025
Worth noting
- The team shrank two years in a row.
- Little cash and receivables against the short-term debts.
- Figures corrected afterwards (2024).
Revenue
€ 105.6 million
▲ 7% vs 2024
Profit
Growing€ 369.8 million
▲ 6926% vs 2024
Debts
Low€ 232.1 million
▼ 1% vs 2024
ABBOTT from Wavre, company number BE0403044007, closed financial year 2025 with a result of € 369.8 million after tax. For that financial year ABBOTT recorded revenue of € 105.6 million and equity of € 2,104.8 million. Compared with financial year 2024, the result moved from € -5.4 million to € 369.8 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.
What happened at ABBOTT?
What happened at ABBOTT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Maya Wakim stepped down as director. NBB
- Slater Bradley Jay stepped down as director. NBB
- Hasna Nadir stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 369.8 million. Source: NBB ↗
- Maya Wakim became a director. NBB
- Slater Bradley Jay became a director. NBB
- Hasna Nadir became a director. NBB
- New establishment in Wavre. KBO
In short
From € 4.3 million loss in 2023 to € 369.8 million profit in 2025.
Paid € 137,733 in corporate taxes since 2023.
Best year ever: 2025, with € 369.8 million profit.
Pays suppliers within 55 days on average.
A new publication or filing at ABBOTT? We notify you, reason included.
Follow ABBOTTNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by St Jude Medical International Holding (100%) and Abbott Holding Gibraltar Limited (0%). It owns 100% of Abbott Medical Italia SPA, 100% of Abbott Medical Belgium BV, 100% of ABBOTT srl, 100% of KNOLL UK INVESTMENTS UNLIMITED, 100% of Abbott Norge AS and 100% of Abbott Medical Hellas itself.
Directors
According to the 2025 annual accounts
Hasna Nadir
Director
since 2022 · until 2027
Maya Wakim
Director
since 2026 · until 2031
Slater Bradley Jay
Director
since 2022 · until 2028
Shareholders
St Jude Medical International Holding
100%
Abbott Holding Gibraltar Limited
0%
Participations
Abbott Medical Italia SPA
100%
ABBOTT srl
100%
KNOLL UK INVESTMENTS UNLIMITED
100%
Abbott Norge AS
100%
Abbott Medical Hellas
100%
ABBOTT LABORATORIOS LDA
100%
ABBOTT ASIA INVESTMENTS LTD
100%
Establishments
Establishment units
Physical locations of this company
Avenue Einstein 14
1300 Wavre
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Details
- Company number
- 0403.044.007
- VAT number
- BE 0403.044.007
- Registered office
- Avenue Einstein 14, 1300 Wavre
- Names & denominations
- ABBOTT
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 6 September 1948
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten